Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportOncology, Basic and Translational - Early Phase (Phase 0 or I) human studies

Optimal imaging timepoint for diagnostic performance of 203Pb-VMT-α-NET SPECT/CT in neuroendocrine tumors

Sanchay Jain, Stephen Graves, Kellie Bodeker, Kristin Gaimari-Varner, Chandrikha Chandrasekharan, Michael Schultz, Yusuf Menda and David Bushnell
Journal of Nuclear Medicine June 2024, 65 (supplement 2) 242347;
Sanchay Jain
1University of Iowa Hospitals and Clinics
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Stephen Graves
1University of Iowa Hospitals and Clinics
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kellie Bodeker
2University of Iowa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kristin Gaimari-Varner
1University of Iowa Hospitals and Clinics
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Chandrikha Chandrasekharan
1University of Iowa Hospitals and Clinics
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael Schultz
3The University of Iowa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yusuf Menda
2University of Iowa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
David Bushnell
2University of Iowa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Article Information

vol. 65 no. supplement 2 242347

Published By 
Society of Nuclear Medicine
Print ISSN 
0161-5505
Online ISSN 
2159-662X
History 
  • Published online June 9, 2024.

Copyright & Usage 
© 2024

Author Information

  1. Sanchay Jain1,
  2. Stephen Graves1,
  3. Kellie Bodeker2,
  4. Kristin Gaimari-Varner1,
  5. Chandrikha Chandrasekharan1,
  6. Michael Schultz3,
  7. Yusuf Menda2 and
  8. David Bushnell2
  1. 1University of Iowa Hospitals and Clinics
  2. 2University of Iowa
  3. 3The University of Iowa

Statistics from Altmetric.com

Cited By...

  • Citations
  • Google Scholar

This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.

Article usage

Article usage: June 2024 to April 2025

AbstractFullPdf
Jun 20243800
Jul 202415200
Aug 202410900
Sep 20243800
Oct 20244500
Nov 20245500
Dec 20245900
Jan 20256300
Feb 20256300
Mar 20253000
Apr 20254200
Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 65, Issue supplement 2
June 1, 2024
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Optimal imaging timepoint for diagnostic performance of 203Pb-VMT-α-NET SPECT/CT in neuroendocrine tumors
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Optimal imaging timepoint for diagnostic performance of 203Pb-VMT-α-NET SPECT/CT in neuroendocrine tumors
Sanchay Jain, Stephen Graves, Kellie Bodeker, Kristin Gaimari-Varner, Chandrikha Chandrasekharan, Michael Schultz, Yusuf Menda, David Bushnell
Journal of Nuclear Medicine Jun 2024, 65 (supplement 2) 242347;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Optimal imaging timepoint for diagnostic performance of 203Pb-VMT-α-NET SPECT/CT in neuroendocrine tumors
Sanchay Jain, Stephen Graves, Kellie Bodeker, Kristin Gaimari-Varner, Chandrikha Chandrasekharan, Michael Schultz, Yusuf Menda, David Bushnell
Journal of Nuclear Medicine Jun 2024, 65 (supplement 2) 242347;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Al18F-NOTA-HER2-BCH affibody PET imaging accurately map HER2 positive lesions of breast cancer
  • Molecular imaging of acute radiation-induced esophagitis using [18F]AlF labeled polypeptide targeting C-X-C-chemokine-receptor-type-4
  • A Phase I/IIa of [212Pb]VMT--NET Targeted Alpha-Particle Therapy for Advanced SSTR2 Positive Neuroendocrine Tumors
Show more Oncology, Basic and Translational - Early Phase (Phase 0 or I) human studies

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire